Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...
Clark said on Monday it plans to acquire Band-Aid maker Kenvue, even as the latter company faces thousands of lawsuits ...
Kenvue stock soars as Kimberly-Clark agrees to acquire the consumer health giant. Jim Cramer is positive on KVUE shares ...
Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.
Kimberly-Clark’s third-quarter profit fell 51% as a result of divestitures, business exits and recent tariffs, although sales ...